A rating of 31 puts BioXcel Therapeutics Inc (BTAI) near the bottom of the Biotechnology industry according to InvestorsObserver. BioXcel Therapeutics Inc's score of 31 means it scores higher than 31% of stocks in the industry. BioXcel Therapeutics Inc also received an overall rating of 40, putting it above 40% of all stocks. Biotechnology is ranked 20 out of the 148 industries.
BTAI has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on BTAI!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With BioXcel Therapeutics Inc Stock Today?
BioXcel Therapeutics Inc (BTAI) stock is trading at $2.80 as of 9:37 AM on Monday, Mar 25, a drop of -$0.01, or -0.53% from the previous closing price of $2.81. The stock has traded between $2.60 and $2.82 so far today. Volume today is light. So far 156,228 shares have traded compared to average volume of 2,477,674 shares.
Click Here to get the full Stock Report for BioXcel Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
